Loading...

Call for Abstracts

Be part of the largest endocrinology & diabetes congress in the region


Depending on the number of submitted abstracts and their quality, the abstracts will be selected for either platform or for poster presentation. All accepted abstracts will be distributed in the meeting abstract book.

You are invited to submit abstracts for the Fifth Clinical Congress and the Gulf Chapter Annual Meeting to be held at Grand Hyatt Hotel in Dubai, United Arab Emirates during the period of October 5-7, 2017

Abstracts submissions are possible until August 3, 2017 (12 AM Dubai time +4 GMT). Any abstract received after the deadline will not be accepted. Upon completion of evaluation an ‘Accepted’ or ‘Rejected’ email will be sent to each application submitted. The result of the evaluation will be send approximately 14 days after deadline submission.

All abstracts accepted will be published in the Ibnosina Journal of Medicine and Biomedical Sciences

Abstract Categories

Abstract Submission Topics


  • Diabetes
  • Disorders of Sex Differentiation
  • Disorders of the Adrenal Gland
  • Calcium and Bone Health
  • Genetic Endocrinology
  • Education in Pediatric Endocrinology and Diabetes
  • Disorders of Glucose metabolism
  • Disorders of Lipid metabolism
  • Obesity and related complications
  • Growth disorders
  • Disorders of the Pituitary Gland
  • Disorders of Puberty
  • Thyroid Disorders

Abstract Guidelines

Please read this section very carefully as all abstract submissions will be evaluated primarily based on the below followed by scientific content.


ABSTRACT GUIDELINES

Language:

  • All submitted abstracts must be in English

 

Author(s):

  • The content of the abstract is solely the responsibility of the author. The original abstract is reprinted exactly as provided. During submission, it must clearly indicate the name of the presenting author, who will be considered the contact person for all correspondence connected with the submitted abstract.
  • All submitted abstracts need to have the names and surnames of all co-authors, along with their positions in their affiliated institutions.

 

Length:

  • Poster & Oral submissions need to be limited to 300 words.

 

Title:

  • An abstract must have a short, specific title (no abbreviations) that clearly indicates the nature of the investigation. It is encouraged that the title is set so as to attract the audience and to hint to the conclusion of the investigation.

 

Content:

  • A well-written abstract typically has the following identified sections:
    1. Background/objectives: a brief introduction, which states the problem that you are addressing as well as some background information on the issue. The introduction of the abstract should include a very brief background 1-2 statements followed by the objectives of the investigation.
    2. Design and methods: the methodologies, number of test subjects and scientific approach used to conduct the research.
    3. Results: it is expected that authors present data that support their conclusion. Tables and graphs should include explanatory captions.
    4. Conclusions: further areas of research and overall conclusion of the research
    5. Citation: a reference list and acknowledgements, if applicable

Co-Author Approval


The submitting author must verify that all co-authors have read and approved the submission of the abstract.

Disclosure


A disclosure form identifying commercial relationships for all co-authors must be completed by the submitting author, if their abstract has been accepted for publication. The submitting author signs and verifies disclosure on behalf of all co-authors. Disclosure information for accepted abstracts will be made available to the meeting attendees.

Acceptance and Rejection


Upon completion of the evaluation of submitted abstracts, an ‘Accepted’ or ‘Rejected’ email will be sent to authors. Upon acceptance of an author’s submission, the following instructions below are applicable:

  • The presenting author of the presentation should confirm their attendance upon receiving the acceptance email within one week.
  • The availability of any sort of grant for registration, travel and/or accommodation will be mentioned in the acceptance email, without any guarantees at the abstract submission stage.
  • Accepted authors will receive one complimentary registration pass that will be conducted by the PCO and sent up to 10 days prior to the congress
  • Authors who confirm presence will receive a free communication code based on their category of submission up to 10 days before the congress.